October 25, 2023
Jude Jackson climbs up the pool slide, navigates the net of an obstacle course, and rides a bike with training wheels. These may seem like simple tasks, but they are miracle milestones for a 4-year-old boy with cerebral palsy who weighed less than 3 pounds at birth.
October 24, 2023
Two different regions of the brain are critical to integrating semantic information while reading, which could shed more light on why people with aphasia have difficulty with semantics, according to new research from UTHealth Houston.
October 23, 2023
With no known history of spina bifida on either side of their families, Shelly Casey and her husband, Chuck, were shocked to learn their yet-to-be-born daughter, Alison, would have the condition, also known as “split spine.”
October 23, 2023
Zhiqiang An, PhD, has been named UTHealth Houston’s first vice president of drug discovery. In this new role, An will work in close collaboration with researchers across campus, as well as the Office of Technology Management, Academic and Faculty Affairs, and the Office of the President to promote drug discovery and therapeutic innovation.
October 20, 2023
Just as a song can remind us of the junior high dance or prom, sounds also have the ability to return traumatic memories.
Pinpointing the location of these traumatic memories is the work behind a clinical trial, “Neuromodulation of the fear extinction circuit using temporally and anatomically specific TMS in humans,” led by Mohammed Milad, PhD, professor in the Louis A. Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston.
October 19, 2023
The Texas Therapeutics Institute at UTHealth Houston, led by Zhiqiang An, PhD, is expanding into the Texas Medical Center’s newly completed TMC3 Collaborative Building.
The institute, part of The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases with McGovern Medical School at UTHealth Houston, focuses on antibody drug resistance mechanisms, biomarkers for therapeutic antibodies, and antibody drug discovery targeting human diseases.
October 18, 2023
A five-year, $6.4 million grant to develop an integrated, multiscale artificial intelligence (AI) approach to study genetic factors associated with Alzheimer’s disease has been awarded to UTHealth Houston by the National Institute on Aging, part of the National Institutes of Health.
October 16, 2023
Robert D. Spears, PhD, MS, and Jennifer L. Swails, MD, FACP, were among the 14 recipients of The University of Texas System Board of Regents’ Outstanding Teaching Award for 2023.
October 11, 2023
Demetrios Stroubakis, 55, thought he was having a gallbladder attack when he arrived at the emergency room in August 2021 with jaundice. Instead, he was shocked to be diagnosed with pancreatic cancer.
October 6, 2023
The offspring of adolescent and young adult women with a history of cancer face a higher risk of birth defects, according to new research from UTHealth Houston.